Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase

Cellular Signalling

Volumn 19, Issue 1, 2007, Pages 139-151

  Boudreau, Robert T M ^a   Conrad, David M ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Caspase; Leukemia; Mitochondrion; p38 MAPK; PP2A

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; DNA FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE P38; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; T CELL LEUKEMIA; TIME;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; DNA FRAGMENTATION; HUMANS; INTRACELLULAR MEMBRANES; LEUKEMIA, T-CELL; MEMBRANE POTENTIAL, MITOCHONDRIAL; OKADAIC ACID; OLIGOPEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERMEABILITY; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 33845367029     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2006.05.030     Document Type: Article

References (46)

1. Cohen P., and Cohen P.T. J. Biol. Chem. 264 (1989) 21435
2. Oliver C.J., and Shenolikar S. Front. Biosci. 3 (1998) D961
3. Bialojan C., and Takai A. Biochem. J. 256 (1988) 283
4. Boudreau R.T., and Hoskin D.W. Int. Immunopharmacol. 5 (2005) 1507
5. Janssens V., and Goris J. Biochem. J. 353 Pt 3 (2001) 417
6. Fernandez J.J., Candenas M.L., Souto M.L., Trujillo M.M., and Norte M. Curr. Med. Chem. 9 (2002) 229
7. Millward T.A., Zolnierowicz S., and Hemmings B.A. Trends Biochem. Sci. 24 (1999) 186
8. Van Hoof C., and Goris J. Biochim. Biophys. Acta 1640 (2003) 97
9. Ruvolo P.P., Clark W., Mumby M., Gao F., and May W.S. J. Biol. Chem. 277 (2002) 22847
10. Harmala-Brasken A.S., Mikhailov A., Soderstrom T.S., Meinander A., Holmstrom T.H., Damuni Z., and Eriksson J.E. Oncogene 22 (2003) 7677
11. Chatfield K., and Eastman A. Biochem. Biophys. Res. Commun. 323 (2004) 1313
12. Benito A., Lerga A., Silva M., Leon J., and Fernandez-Luna J.L. Leukemia 11 (1997) 940
13. Ishida Y., Furukawa Y., Decaprio J.A., Saito M., and Griffin J.D. J. Cell. Physiol. 150 (1992) 484
14. Lerga A., Richard C., Delgado M.D., Canelles M., Frade P., Cuadrado M.A., and Leon J. Biochem. Biophys. Res. Commun. 260 (1999) 256
15. Riordan F.A., Foroni L., Hoffbrand A.V., Mehta A.B., and Wickremasinghe R.G. FEBS Lett. 435 (1998) 195
16. Gendron S., Couture J., and Aoudjit F. J. Biol. Chem. 278 (2003) 48633
17. Chang L., and Karin M. Nature 410 (2001) 37
18. Johnson G.L., and Lapadat R. Science 298 (2002) 1911
19. Seger R., and Krebs E.G. FASEB J. 9 (1995) 726
20. Tibbles L.A., and Woodgett J.R. Cell. Mol. Life Sci. 55 (1999) 1230
21. Wada T., and Penninger J.M. Oncogene 23 (2004) 2838
22. Arbabi S., and Maier R.V. Crit. Care Med. 30 1 Supp (2002) S74
23. Liu Q., and Hofmann P.A. Am. J. Physiol, Heart Circ. Physiol. 285 (2003) H97
24. Westermarck J., Li S.P., Kallunki T., Han J., and Kahari V.M. Mol. Cell. Biol. 21 (2001) 2373
25. Zhu C.B., Carneiro A.M., Dostmann W.R., Hewlett W.A., and Blakely R.D. J. Biol. Chem. 280 (2005) 15649
26. Boudreau R.T., Hoskin D.W., and Lin T.J. J. Leukoc. Biol. 76 (2004) 1075
27. Alvarado-Kristensson M., and Andersson T. J. Biol. Chem. 280 (2005) 6238
28. Sundaresan P., and Farndale R.W. FEBS Lett. 528 (2002) 139
29. Lee T., Kim S.J., and Sumpio B.E. J. Cell. Physiol. 194 (2003) 349
30. Liu Q., and Hofmann P.A. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H2204
31. Matzinger P. J. Immunol. Methods 145 (1991) 185
32. Castedo M., Ferri K., Rumier T., Metivier D., Zamzami N., and Kroemer G. J. Immunol. Methods 265 (2002) 39
33. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Nwemeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., and Martin S.J. J. Cell Biol. 144 (1999) 281
34. Wilson K.P., Fitzgibbon M.J., Caron P.R., Griffith J.P., Chen W., McCaffrey P.G., Chambers S.P., and Su M.S. J. Biol. Chem. 271 (1996) 27696
35. Breckenridge D.G., and Xue D. Curr. Opin. Cell Biol. 16 (2004) 647
36. Van de Craen M., Declercq W., Van den brande I., Fiers W., and Vandenabeele P. Cell Death Differ. 6 (1999) 1117
37. Bossy-Wetzel E., and Green D.R. J. Biol. Chem. 274 (1999) 17484
38. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cell 91 (1997) 479
39. von Haefen C., Wieder T., Essmann F., Schulze-Osthoff K., Dorken B., and Daniel P.T. Oncogene 22 (2003) 2236
40. Perchellet E.M., Wang Y., Weber R.L., Sperfslage B.J., Lou K., Crossland J., Hua D.H., and Perchellet J.P. Biochem. Pharmacol. 67 (2004) 523
41. Simizu S., Tamura Y., and Osada H. Cancer Sci. 95 (2004) 266
42. Park S.J., and Kim I.S. Br. J. Pharmacol. 146 (2005) 506
43. Kutuk O., Pedrech A., Harrison P., and Basaga H. Apoptosis 10 (2005) 597
44. Koizumi K., Tanno S., Nakano Y., Habiro A., Izawa T., Mizukami Y., Okumura T., and Kohgo Y. Anticancer Res. 25 (2005) 3347
45. Huang J., Wu L., Tashiro S., Onodera S., and Ikejima T. Biol. Pharm. Bull. 28 (2005) 2068
46. Vega M.I., Huerta-Yepaz S., Garban H., Jazirehi A., Emmanouilides C., and Bonavida B. Oncogene 23 (2004) 3530